For a patient in a hospital bed, a suspected seizure is a race against the clock. The gold standard for diagnosis is continuous electroencephalography (cEEG), where electrodes track brainwave activity for hours or days. But in many hospitals, especially outside major academic centers, the specialized technologists to run and interpret these tests are simply not on staff. Next Gen Neuro, a remote neurodiagnostics company based in Plainfield, Indiana, is building a business on that precise, persistent gap. It operates a distributed team of over 150 credentialed specialists who monitor patients in real time from afar, offering hospitals a way to provide a critical service without the capital and staffing overhead of an in-house neurology department [Perplexity Sonar, Unknown].
The Wedge in a Staffing Crisis
The company’s bet is straightforward: it sells access, not equipment. Next Gen Neuro provides five core EEG services, including real-time continuous monitoring, all billed under the updated 2020 CPT codes that govern reimbursement for such procedures [Next Gen Neuro website, Unknown]. For a hospital partner, the value proposition is operational relief. The company enforces a patient-to-technologist ratio of 4:1 for continuous monitoring, a staffing standard that many facilities would struggle to meet on their own [Next Gen Neuro website, Unknown]. This allows a community hospital, for instance, to offer advanced neurodiagnostic care that might otherwise require transferring a fragile patient. The model appears to be scaling through commercial capital alone; the company reports no outside funding rounds but has grown to an estimated 156 employees while generating under $5 million in annual revenue [Perplexity Sonar, Unknown].
Clinical Credentials Over Venture Hype
Leadership at Next Gen Neuro is clinical first. Co-founders CEO Leisha Osburn and COO Amanda Ritchey built the company from their experience in the neurodiagnostics field. Ritchey holds a suite of credentials including REEGT (Registered EEG Technologist) and CLTM (Certified Long-Term Monitoring), signaling a deep grounding in the practical realities of the work [Amanda Ritchey LinkedIn, Unknown]. The company emphasizes that its clinical leadership team holds over 50 years of combined EEG experience and is willing to step in to monitor patients directly when needed [Next Gen Neuro careers, Unknown]. This focus on hands-on expertise is a deliberate contrast to the AI-driven diagnostic tools flooding the healthtech space. Next Gen Neuro’s differentiation is its people network, a credentialed workforce that can be deployed remotely via software partnerships, like its 2022 collaboration with hardware maker Zeto Inc. [Zeto, Aug 2022].
| Role | Name | Key Credentials / Notes |
|---|---|---|
| Chief Executive Officer | Leisha Osburn | Co-founder, owner [RocketReach, Unknown] |
| Chief Operating Officer | Amanda Ritchey | Co-founder, MHA, REEGT, NA-CLTM, CNIM [Amanda Ritchey LinkedIn, Unknown] |
| Director of Clinical Operations | Sedalia Cole | R. EEG T, CLTM [RocketReach, Unknown] |
The Counterfactual: Scale and Specialization
The company’s bootstrapped, services-heavy model carries inherent constraints as it looks to grow. Its revenue footprint remains modest, and expanding its specialist headcount in a tight labor market is a constant challenge, evidenced by ongoing recruiting for remote neurologists and EEG analysts [Next Gen Neuro, Unknown]. Furthermore, the service is inherently human-scaled; each interpreting neurologist or monitoring technologist can only handle so many concurrent patients. This contrasts with pure software or AI diagnostic plays that promise infinite scalability. Next Gen Neuro’s rebuttal is likely that brainwave interpretation, especially for critical conditions like non-convulsive status epilepticus, still requires a human expert’s judgment. The regulatory environment supports this view: these are billable medical procedures under a physician’s supervision, not software-as-a-medical-device applications that would face a different FDA pathway.
For patients with conditions like epilepsy, traumatic brain injury, or unexplained altered mental status, timely cEEG monitoring can be diagnostic and even life-saving. The standard of care today is a patchwork. In well-resourced tertiary care centers, dedicated neuro-ICU teams provide 24/7 monitoring. In many other hospitals, the service is unavailable or relies on an on-call neurologist who may not be immediately present. Delays in initiating monitoring can lead to missed diagnoses and prolonged hospital stays. Next Gen Neuro is attempting to level that field, bringing a consistent, remote monitoring service to the neonatal, pediatric, and adult patients who otherwise might not have access. Its success will be measured not in algorithm accuracy, but in how many hospitals can keep a patient in their own bed, connected to a specialist hundreds of miles away.
Sources
- [Perplexity Sonar, Unknown] Next Gen Neuro Company Snapshot | https://www.teamngn.com/
- [Next Gen Neuro website, Unknown] Remote cEEG & EEG Monitoring Services | https://www.teamngn.com/services
- [Amanda Ritchey LinkedIn, Unknown] Amanda Ritchey Professional Profile | https://www.linkedin.com/in/amanda-ritchey-mha-reegt-na-cltm-cnim-9bb59141/
- [Next Gen Neuro careers, Unknown] About Our Team | https://www.teamngn.com/about-us
- [Zeto, Aug 2022] Zeto and Next Gen Neuro Partner for Remote EEG Monitoring | https://zeto-inc.com/news/zeto-and-next-gen-neuro-partner-for-remote-eeg-monitoring/
- [RocketReach, Unknown] Next Gen Neuro Team Data | https://www.zoominfo.com/c/next-gen-neuro/478370409
- [Next Gen Neuro, Unknown] Remote Interpreting Neurologist Job Posting | https://www.teamngn.com/job-posting-remote-interpreting-neurologist-epileptologist